EMA Specifies New Warnings For Codeine/Ibuprofen Combination Drugs
Executive Summary
A warning about the risk of severe hypokalemia and renal tubular acidosis is set to be added to the product information of fixed dose combinations of codeine and ibuprofen marketed in the EU following an investigation by the EMA's PRAC.
You may also be interested in...
Ireland Reviewing Codeine's OTC Status
Ireland’s drug regulator HPRA has initiated a formal regulatory procedure to determine if OTC remains the appropriate classification for codeine-containing products. The agency says the move is in response to a growing understanding of the potential impacts of addiction to codeine at low doses.
EMA Starts Safety Review Of Cough Drugs Containing Pholcodine
The European Medicines Agency is reviewing the safety of cough suppressants containing the opioid pholcodine after a French study found new evidence linking these products to an increased risk of anaphylactic reactions to drugs used in general anesthesia.
'Purple Drank' Drug Cocktail Linked To France's Latest Reverse-Switch
Promethazine has been reverse-switched from OTC to prescription status in France, with rising abuse of the drug in the so-called Purple Drank cocktail one of the motivating factors for the move by the country's health ministry.